Brand Watch — April 10, 2026
Every Wednesday, Brand Watch analyzes a significant market move in the fitness and wellness sector. This week: WHOOP's funding round, one of the largest in wearable history.
The deal
On March 31, 2026, WHOOP announced the close of a $575 million Series G round. Post-round valuation: $10.1 billion. Its previous valuation was $3.6 billion. That's nearly a triple in a single round.
The round was led by Collaborative Fund. Investors include Qatar Investment Authority and Mubadala Investment Co. (sovereign wealth funds), Abbott and Mayo Clinic (medical institutions), and Cristiano Ronaldo and LeBron James (sports ambassadors turned shareholders).
What the numbers say
WHOOP shared some metrics to support the valuation. In 2025, bookings grew 103% year over year. The company is operating cash flow positive and running at a $1.1 billion annual run rate. It has 2.5 million active members worldwide.
For context: Garmin trades at roughly $25 billion with a much broader product line. Polar and Suunto aren't public, but their estimated valuations are substantially lower. WHOOP sits between niche and mass market, with a value proposition centered on recovery and performance. For a broader picture of how challenger brands are reshaping premium fitness valuations, Vuori's $5.5B IPO trajectory offers a useful parallel.
The most important signal: Abbott and Mayo Clinic
In a growth fund-led round, the presence of Abbott and Mayo Clinic is unusual and significant. These aren't traditional financial investors.
Abbott is one of the world's leading makers of continuous glucose monitors (CGMs). Mayo Clinic is a leading institution in preventive medicine. Their participation signals that WHOOP isn't just positioned as a fitness gadget. It's preparing for integration with metabolic monitoring and clinical health.
This is the same strategic move Apple made with ECG and fall detection features. Fitness wearables are becoming health infrastructure — a shift also visible in Oura's acquisition of gesture-AI startup Doublepoint as it builds toward a full ambient biometric platform.
The path to IPO
Bloomberg reported that this raise is positioned as a step toward an IPO, likely in 2026 or early 2027. WHOOP announced hiring for over 600 roles, primarily at its Boston headquarters.
For brands in the fitness sector, this trajectory has direct implications. If WHOOP goes public at a 10+ billion valuation, it sets a precedent and a reference point for valuing other players in the space. It also raises expectations around reporting and transparency across the wearable market.
What it says about the market in 2026
Fitness wearables were long seen as enthusiast gadgets. WHOOP's 2026 raise marks a turning point: institutional health investors now view them as Class II medical devices, not sports accessories.
For brands wanting to compete in this market, the technical and regulatory bar is rising. The FDA and European equivalents (CE Medical) are starting to regulate certain health claims from wearables. That's a constraint, but also a moat that protects established players.